The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 03, 2025
Filed:
Feb. 07, 2023
Applicant:
Olatec Therapeutics Llc, New York, NY (US);
Inventors:
Carlo Marchetti, Denver, CO (US);
Charles A. Dinarello, Boulder, CO (US);
Assignee:
OLATEC THERAPEUTICS, INC., New York, NY (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/275 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/275 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/4866 (2013.01); A61P 9/04 (2018.01); A61P 9/10 (2018.01);
Abstract
The present invention is directed to a method for treating cardiovascular diseases such as acute myocardial infarction, atherosclerosis, heart failure, stroke, thrombosis, carditis (including acute myocarditis, acute pericarditis and complicated pericarditis), cardiac allograft rejection, cardiomyopathy, and peripheral vascular diseases. The method comprises administering to a subject in need thereof dapansutrile, in an effective amount. A preferred route of administration is oral administration.